Efficacy of OK-432 sclerotherapy for different types of lymphangiomas: a review and meta-analysis.

ABSTRACT:

Objective

This study aims to perform a meta-analysis to figure out the efficacy of OK-432 sclerotherapy between Macrocystic (MAC) lymphangiomas and Microcystic (MIC) lymphangiomas.

Methods

We conducted a systematic review and meta-analysis to clarify the relationship between OK-432 and lymphangiomas. PubMed and ISI Web of Science were searched from inception to May 2022. Joanna Briggs Institute (JBI) manual was used to evaluate the risk of bias. We calculated pooled Relative Risks (RR) and 95% Confidence Interval (95% CI) using random effects model to evaluate the relations between OK-432 and lymphangiomas.

Results

A total of 11 studies (including 352 cases) about OK-432 sclerotherapy for lymphangioma were included in the current meta-analyses. The results suggested t

SUBMITTER: Sun J 

PROVIDER: S-EPMC10300298 | biostudies-literature | 2023 Jul-Aug

REPOSITORIES: biostudies-literature